OA10847A - Azole compounds endowed with antimycotic activity for human and veterinary use - Google Patents

Azole compounds endowed with antimycotic activity for human and veterinary use Download PDF

Info

Publication number
OA10847A
OA10847A OA9800152A OA9800152A OA10847A OA 10847 A OA10847 A OA 10847A OA 9800152 A OA9800152 A OA 9800152A OA 9800152 A OA9800152 A OA 9800152A OA 10847 A OA10847 A OA 10847A
Authority
OA
OAPI
Prior art keywords
chloro
hydrogen
formula
fluoro
compounds
Prior art date
Application number
OA9800152A
Other languages
English (en)
Inventor
Mauro Napoletano
Cristina Fraire
Enrico Albini
Giovanna Schioppacassi
Original Assignee
Zambon Spa
Isagro Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa, Isagro Spa filed Critical Zambon Spa
Publication of OA10847A publication Critical patent/OA10847A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Devices For Medical Bathing And Washing (AREA)
OA9800152A 1996-02-28 1998-08-28 Azole compounds endowed with antimycotic activity for human and veterinary use OA10847A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000371A IT1283038B1 (it) 1996-02-28 1996-02-28 Composti azolici ad attivita' antimicotica per uso umano e veterinario

Publications (1)

Publication Number Publication Date
OA10847A true OA10847A (en) 2003-02-05

Family

ID=11373418

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9800152A OA10847A (en) 1996-02-28 1998-08-28 Azole compounds endowed with antimycotic activity for human and veterinary use

Country Status (32)

Country Link
US (2) US5869512A (de)
EP (1) EP0877739B1 (de)
JP (1) JP2000505466A (de)
KR (1) KR19990087363A (de)
CN (1) CN1082050C (de)
AP (1) AP9801328A0 (de)
AT (1) ATE219066T1 (de)
AU (1) AU713049B2 (de)
BG (1) BG102711A (de)
BR (1) BR9707773A (de)
CA (1) CA2247390A1 (de)
CZ (1) CZ291790B6 (de)
DE (1) DE69713276T2 (de)
DK (1) DK0877739T3 (de)
EA (1) EA003189B1 (de)
EE (1) EE03684B1 (de)
ES (1) ES2176689T3 (de)
GE (1) GEP20002091B (de)
HU (1) HUP9900569A3 (de)
IL (1) IL125701A (de)
IT (1) IT1283038B1 (de)
NO (1) NO983953L (de)
NZ (1) NZ331919A (de)
OA (1) OA10847A (de)
PL (1) PL328582A1 (de)
PT (1) PT877739E (de)
SI (1) SI0877739T1 (de)
SK (1) SK283391B6 (de)
TR (1) TR199801688T2 (de)
UA (1) UA55405C2 (de)
WO (1) WO1997031903A1 (de)
ZA (1) ZA971665B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296925B1 (it) 1997-12-05 1999-08-03 Zambon Spa Procedimento per la preparazione di composti ad attivita' antimicotica
US6297115B1 (en) * 1998-11-06 2001-10-02 Advanced Micro Devices, Inc. Cmos processs with low thermal budget
AU2003211498A1 (en) 2002-02-15 2003-09-04 Mitsui Chemicals, Inc. Optically active azole derivative and process for producing the same
GB0222964D0 (en) 2002-10-03 2002-11-13 Unilever Plc Polymeric film for water soluble package

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU187399B (en) * 1980-12-24 1985-12-28 Sumitomo Chemical Co Process for preparing imidazolyl-propanol derivatives
EP0061835B1 (de) * 1981-03-18 1989-02-01 Imperial Chemical Industries Plc Triazolverbindungen, Verfahren zu deren Herstellung, deren Anwendung als Pflanzenfungizide und deren fungizide Zusammensetzungen
DE3271901D1 (en) * 1982-02-03 1986-08-07 Ici Plc Heterocyclic compounds useful as pesticides and processes for making them
US4505919A (en) * 1982-10-09 1985-03-19 Pfizer Inc. Antifungal S-arylmethyl- and S-heterocyclylmethyl ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols
AU572889B2 (en) * 1983-09-26 1988-05-19 Sumitomo Chemical Company, Limited 1,2,4 - triazolyl propanols
KR930004193B1 (ko) * 1984-10-02 1993-05-21 스미또모 세이야꾸 가부시끼가이샤 N-치환된 트리아졸 유도체의 제조방법
US5081138A (en) * 1986-12-17 1992-01-14 Merck Frosst Canada, Inc. 3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith
IT1198240B (it) * 1986-12-23 1988-12-21 Agrimont Spa Azolilderivati fungicidi
IT1232943B (it) * 1987-11-09 1992-03-10 Mini Ricerca Scient Tecnolog Azolilderivati fungicidi.
US5134152A (en) * 1989-12-07 1992-07-28 Sankyo Company, Limited Oxetane derivatives and their use as anti-fungal or fungicidal agents
CA2031892C (en) * 1989-12-25 2000-08-01 Minoru Tokizawa Triazole derivatives
CA2049802A1 (en) * 1990-08-26 1992-02-27 Sadao Oida Anti-fungal triazole derivatives, their preparation and uses
GB9307924D0 (en) * 1993-04-16 1993-06-02 Zeneca Ltd Chrial synthesis
CA2145458A1 (en) * 1994-03-28 1995-09-29 Hiroki Kodama Triazole compound and production process and use thereof
IT1273509B (it) * 1995-04-07 1997-07-08 Zambon Spa Composti azolici ad attivita' antimicotica per uso umano e veterinario

Also Published As

Publication number Publication date
AU713049B2 (en) 1999-11-25
HUP9900569A1 (hu) 1999-06-28
EP0877739B1 (de) 2002-06-12
ES2176689T3 (es) 2002-12-01
SK116198A3 (en) 1999-02-11
IL125701A (en) 2003-11-23
HUP9900569A3 (en) 2001-07-30
EA199800693A1 (ru) 1999-06-24
DE69713276D1 (de) 2002-07-18
CZ274898A3 (cs) 1999-01-13
UA55405C2 (uk) 2003-04-15
EE9800261A (et) 1999-02-15
CN1082050C (zh) 2002-04-03
DK0877739T3 (da) 2002-10-07
NO983953D0 (no) 1998-08-27
PT877739E (pt) 2002-11-29
KR19990087363A (ko) 1999-12-27
EE03684B1 (et) 2002-04-15
ATE219066T1 (de) 2002-06-15
AU2092997A (en) 1997-09-16
EP0877739A1 (de) 1998-11-18
NZ331919A (en) 1999-04-29
DE69713276T2 (de) 2003-03-06
EA003189B1 (ru) 2003-02-27
ZA971665B (en) 1997-08-29
IL125701A0 (en) 1999-04-11
US5869512A (en) 1999-02-09
PL328582A1 (en) 1999-02-01
WO1997031903A1 (en) 1997-09-04
ITMI960371A1 (it) 1997-08-28
JP2000505466A (ja) 2000-05-09
CN1212685A (zh) 1999-03-31
CZ291790B6 (cs) 2003-05-14
ITMI960371A0 (de) 1996-02-28
BR9707773A (pt) 2000-01-04
IT1283038B1 (it) 1998-04-07
SI0877739T1 (en) 2002-12-31
BG102711A (bg) 1999-04-30
GEP20002091B (en) 2000-05-10
US6103909A (en) 2000-08-15
AP9801328A0 (en) 1998-09-30
NO983953L (no) 1998-10-26
SK283391B6 (sk) 2003-07-01
TR199801688T2 (xx) 1998-11-23
CA2247390A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
US4916134A (en) 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE53144B1 (en) Triazole antifungal agents,processes for preparing them,and pharmaceutical compositions containing them
RO108453B1 (ro) Derivati de 1h-1,2,4 triazol, procedee si intermediari pentru prepararea acestora
DE69231445T2 (de) Triazole enthaltende antifungizide mittel
EP0283992B1 (de) 4-[4-[4-[4-[[2-(2,4-Difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]-methoxy]phenyl]-1-piperazinyl]phenyl]triazolone
JPS6345672B2 (de)
FI82038B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara triazolfoereningar.
EP0115400B1 (de) Fungizid wirkende Triazole
US4483863A (en) Triazole antifungal agents
OA10847A (en) Azole compounds endowed with antimycotic activity for human and veterinary use
US5177094A (en) Triazole compounds having antifungal properties
JPS6346074B2 (de)
US4720546A (en) Intermediates for the preparation of substituted 2-phenyl-1,3-dioxolanes
EP0819124B1 (de) Azolverbindungen mit antimykotischer wirkung für menschliche und tierärzliche verwendung
US4877801A (en) 1-Aryl-1-(1H-azol-1-ylalkyl)-1,3-dihydroisobenzofurans, related derivatives and pharmaceutical compositions thereof useful as antifungals
US4526983A (en) Process for preparing optically active imidazolylpropanol compounds, and intermediate therein
US4767867A (en) 5-(alkoxyalkyl)-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines
EP0257351A2 (de) 3-Phenyl-3-(1H-1,2,4-triazol-1-ylmethyl)-5-substituierte-2-methylisoxazole